172
Participants
Start Date
August 31, 2013
Primary Completion Date
May 31, 2014
Study Completion Date
July 31, 2014
Placebo
RDEA3170 5 mg
RDEA3170 10 mg
RDEA3170 12.5 mg
New York
Altoona
Midlothian
Richmond
Virginia Beach
Winston-Salem
Shelby
Shelby
Charlotte
Wilmington
Hickory
Spartanburg
Mt. Pleasant
Greenville
Greer
Rock Hill
Dunwoody
Jacksonville
Pembroke Pines
Tampa
Winter Haven
Birmingham
Gulf Shores
Mobile
Spring Hill
Jackson
Lexington
Elizabethtown
Perrysburg
Willoughby Hills
Cincinnati
Fargo
Gurnee
Metairie
Houston
Denver
Colorado Springs
Meridian
Bountiful
Glendale
Peoria
Tucson
Reno
Irvine
Anaheim
San Leandro
San Ramon
Gold River
Honolulu
Lead Sponsor
Ardea Biosciences, Inc.
INDUSTRY